HBK Sorce Advisory’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-16,179
Closed -$241K 618
2025
Q1
$241K Buy
+16,179
New +$249K 0.01% 501
2023
Q1
Sell
-9,526
Closed -$266K 770
2022
Q4
$266K Buy
+9,526
New +$244K 0.01% 584
2022
Q2
Sell
-6,240
Closed -$218K 529
2022
Q1
$218K Sell
6,240
-1,019
-14% -$34.8K 0.01% 487
2021
Q4
$221K Sell
7,259
-479
-6% -$15.6K 0.01% 534
2021
Q3
$254K Buy
+7,738
New +$248K 0.01% 479

Other funds holding OGN

HBK Sorce Advisory's OGN Position: Q2 2025 in Review

HBK Sorce Advisory sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 16,179 shares — an estimated $241K sold.

HBK Sorce Advisory first reported a position in OGN in Q3 2021 and held it in 5 quarters. The position peaked at $266K in Q4 2022. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • HBK Sorce Advisory reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • HBK Sorce Advisory sold 16,179 Organon & Co shares in Q2 2025, an estimated $241K.
  • HBK Sorce Advisory first reported a position in Organon & Co in Q3 2021 and held it in 5 quarters.
  • HBK Sorce Advisory's Organon & Co position peaked at $266K in Q4 2022.
  • 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on HBK Sorce Advisory's 13F filing for Q2 2025, filed 4 Aug 2025.